Animal Health Industry: Michael Castor's Next Promising Pick Is Here
Animal health industry: There are hundreds of different "investment gurus" lauded by the financial press as the names retail investors should pay attention to.
Nps Pharmaceuticals Inc (NPSP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 2. | Napier Park Global Capital Jim O'brien And Jonathan Dorfman | 0 | $0 | 0% | |
| 3. | Laurion Capital Management Benjamin A. Smith | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Sabby Capital Hal Mintz | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.09 | 11,000 | Officer | 11,000 | 2012-11-15 | Filing | |
| $5.40 | 20,000 | Officer | 24,560 | 2011-11-10 | Filing | |
| $5.36 | 30,000 | Officer, Director | 132,690 | 2011-11-09 | Filing | |
| $5.36 | 20,000 | Officer | 22,639 | 2011-11-09 | Filing | |
| $5.85 | 3,531 | Director | 58,500 | 2010-11-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $45.87 | 6,711 | Officer | 3,800 | 2015-02-10 | Filing | |
| $45.90 | 32,622 | Officer | 20,151 | 2015-02-05 | Filing | |
| $35.00 | 52,258 | Officer | 72,780 | 2014-12-17 | Filing | |
| $35.00 | 16,467 | Officer | 20,151 | 2014-12-17 | Filing | |
| $34.59 | 3,708 | Director | 7,400 | 2014-12-17 | Filing |
Institutional Investors' Holdings
News See All
Cardinal Health, Inc. (CAH), NPS Pharmaceuticals, Inc. (NPSP), Anacor Pharmaceuticals Inc (ANAC): Checking Back In On Michael Castor's Favorite Healthcare Trio
A few healthcare companies Castor has mentioned he's liked this year are: Cardinal Health, Inc. (NYSE:CAH), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and Anacor Pharmaceuticals Inc (NASDAQ:ANAC).
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets. Two of the most under-the-radar are hedge fund and insider trading activity.
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
To the average investor, there are dozens of indicators market participants can use to analyze their holdings. A pair of the most under-the-radar are hedge fund and insider trading movement.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and insider trading interest.
This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we've seen from the smart money, out of the entire stock market universe and the 500+ elite hedge funds we track.
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World's Most Ultra-Rare Diseases
According to the Food and Drug Administration, a rare disease or disorder is any one that affects 200,000 of fewer people.
Apple Inc. (AAPL), Google Inc (GOOG): The Media is Dead Wrong About Hedge Funds
It’s time to set the record straight. Many members of the media have reacted negatively to the development that hedge funds will be allowed to advertise to the general public.